Insulet Corp. Secures Court Order for EOFlow’s Financial Disclosure in $60 Million Trade Secrets Case

In a significant development, Insulet Corp. is seeking to enforce a nearly $60 million trade secrets judgment against the Korean company EOFlow, a manufacturer of wearable insulin patches. A federal judge in Massachusetts has mandated EOFlow to comply with discovery requests. These requests are crucial as Insulet Corp. aims to gather detailed information regarding EOFlow’s finances. The compliant discovery process will also encompass information tied to an ongoing arbitration with Medtronic PLC, which is linked to a canceled acquisition deal. This ruling highlights complexities within international business litigation and the intricate challenges in navigating trade secret disputes. For further details, refer to the original report by Law360.